Eli Lilly: Xigris (A)

Kellogg School of Management Cases

ISSN: 2474-6568

Publication date: 20 January 2017


Examines the launch of Xigris, a breakthrough new pharmaceutical product for the treatment of sepsis. The newly appointed head of marketing for Xigris is reviewing the launch plan.



Calkins, T. and White, K. (2017), "Eli Lilly: Xigris (A)", Kellogg School of Management Cases. https://doi.org/10.1108/case.kellogg.2016.000108

Download as .RIS



Kellogg School of Management

Copyright © 2004, The Kellogg School of Management at Northwestern University

Please note you might not have access to this content

You may be able to access this content by login via Shibboleth, Open Athens or with your Emerald account.
If you would like to contact us about accessing this content, click the button and fill out the form.